# Safety and Efficacy of Chronic Hypnotic Use 2

> **NCT02456532** · PHASE4 · COMPLETED · sponsor: **Henry Ford Health System** · enrollment: 41 (actual)

## Conditions studied

- Chronic Insomnia

## Interventions

- **DRUG:** placebo
- **DRUG:** Zolpidem CR
- **DRUG:** Eszopiclone

## Key facts

- **NCT ID:** NCT02456532
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-02-22
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02456532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02456532, "Safety and Efficacy of Chronic Hypnotic Use 2". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02456532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*